社区急性肾损伤与急性肾病对肾功能进展及死亡风险的影响
AKD在非CKD和CKD患者中的发病率分别为3.51和12.56/1000患者年。非CKD患者中43.8%进展为CKD,既往CKD患者中63.1%出现eGFR下降>50%。AKD发作后3个月内死亡率为7%,合并AKI者达30.1%。
要点
- 社区AKD在CKD患者中发病率更高,达12.56/1000患者年。
- 非CKD患者发生AKD后43.8%进展为CKD,需重视随访。
- AKD发作后3个月内死亡率7%,合并AKI者高达30.1%。
核心结论
- 社区中血清肌酐急性升高可能带来健康风险并促进CKD发生,应对发作后存活者识别治疗靶点并提供适当随访。
研究设计与样本
- 社区队列研究,纳入1 863 731名年龄>23岁且至少两次血清肌酐检测者,随访4.8年。
- 采用CKD-EPI公式计算eGFR,按KDIGO标准定义CKD、AKD和AKI,并用RIFLE量表分类发作。
主要发现
- 共识别47 972例患者的56 850次AKD发作,非CKD和CKD患者发病率分别为3.51和12.56/1000患者年。
- 87.3%患者发生1次AKD,9.3%发生2次,3.4%发生3次及以上;非CKD患者第二次发作比例10.3%,CKD患者18.4%。
- 非CKD患者中43.8%进展为CKD,既往CKD患者中63.1%出现eGFR下降>50%。
- 5 646例患者发生AKI,其中12.7%进展为CKD,既往CKD者中43.2%出现eGFR下降>20%。
- 总人群AKD发作后3个月内死亡率为7%,合并AKI者死亡率为30.1%。
关键数值与推荐
- AKD和AKI按 harmonized KDIGO 标准(Lameire 2021)定义。
- 使用RIFLE量表(Risk、Injury、Failure、Loss、End-stage)对发作进行分类。
- 进展至CKD风险在女性、高龄、超重肥胖和心力衰竭患者中更高;CKD患者eGFR下降>50%的风险同样受上述因素影响,且AKD发作次数也是危险因素。
临床怎么用
- 社区中发现血清肌酐急性升高应视为CKD进展和死亡的风险标志,需对存活者安排适当随访。
- 对女性和高龄、超重肥胖、合并心力衰竭等高危人群应加强AKD后的肾功能监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND HYPOTHESIS: The aim was to assess incidence of acute kidney disease and disorders (AKD) and acute kidney injury (AKI) episodes and their impact on progression of renal dysfunction and risk of all-cause mortality in the community. METHODS: Community of 1 863 731 aged >23 years with at least two serum creatinine measurements. eGFR was calculated using the chronic kidney disease (CKD)-EPI formula. CKD, AKD and AKI were defined according to the harmonized KDIGO criteria (Lameire 2021). The sCr values and Risk, Injury, Failure, Loss, End-stage (RIFLE) scale was used to classify episodes. Progression of renal dysfunction and mortality were evaluated. RESULTS: A total of 56 850 episodes of AKD in 47 972 patients over 4.8 years were identified. AKD incidence of AKD was 3.51 and 12.56/1000 patients/year in non-CKD and CKD, respectively. One AKD episode was observed in 87.3% patients, two in 9.3%, and three or more in 3.4%. A second episode was less common in patients without CKD (10.3%) compared to those with CKD (18.4%). Among patients without CKD a total of 43.8% progressed to CKD, and those with previous CKD 63.1% had eGFR decline of >50%. The risk of progression to CKD was higher in women, older, overweight-obesity, and heart failure, as was the risk of eGFR decline >50% in CKD patients, although the number of AKD episodes was also a risk factor. AKI episodes were observed in 5646 patients with or without CKD. Of these, 12.7% progressed to CKD and of those with pre-existing CKD, 43.2% had an eGFR decline of >20%. In the total population, mortality within 3 months of detection of AKD episode occurred in 7% patients, and was even higher in patients with AKI at 30.1%. CONCLUSION: Acute elevations in serum creatinine in the community may pose a health risk and contribute to the development of CKD. Identification of therapeutic targets and provision of appropriate follow-up for those who survive an episode is warranted.
引用
- Diaz J, Lidon L, Sauri I, et al. The impact of acute kidney damage in the community. Nephrol Dial Transplant. 2025. PMID: 39049453. doi:10.1093/ndt/gfae175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。